DennisLSpanglerMD

PubMed

• 4 citations
  The role of inhaled corticosteroids in asthma treatment: a health economic perspective.
  Dennis L. Spangler> ;The American Journal of Managed Care. 2012 Jan 24
• 13 citations
  Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by...
  Mark B. Abelson, Dennis L. Spangler, Arthur B Epstein, Francis S. Mah, H.Jerome Crampton> ;Current Eye Research. 2007 Dec 1
• 13 citations
  Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
  Dennis L Spangler, Stephen A. Brunton> ;Southern Medical Journal. 2006 Jun 1
• 41 citations
  Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the c...
  Dennis L. Spangler, Mark B. Abelson, Andrew Ober, Paulo J. Gotnes> ;Clinical Therapeutics. 2003 Aug 1
• 91 citations
  First do no harm: Managing antihistamine impairment in patients with allergic rhinitis
  Thomas B. Casale, Michael S. Blaiss, Erwin W. Gelfand, Timothy Gilmore, Philip D. Harvey, Ian Hindmarch, F. Estelle R. Simons, Dennis L. Spangler, Stanley J. Szefler, ...> ;The Journal of Allergy and Clinical Immunology. 2003 May 1
• 28 citations
  Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhi...
  Bob Q. Lanier, Mark B. Abelson, William E. Berger, David B. Granet, Peter A. D'Arienzo, Dennis L. Spangler, Martin K. Kägi> ;Clinical Therapeutics. 2002 Jul 1
• 44 citations
  Evaluation of the efficacy of olapatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen ch...
  Dennis L. Spangler, George Bensch, Gregg J. Berdy> ;Clinical Therapeutics. 2001 Aug 1
• 55 citations
  A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution ...
  Gregg J. Berdy, Dennis L. Spangler, George Bensch, Susan S. Berdy, Robert C. Brusatti> ;Clinical Therapeutics. 2000 Jul 1
• The use of ketotifen in the prophylaxis of seasonal allergic asthma.
  Tinkelman, D. G., Webb, C. S., Vanderpool, G. E., Carroll, M. S., Spangler, D. L., Lotner, G. Z.> ;Ann Allergy. 1986 Mar
• The effect of diet on the efficacy onset and duration of action of procaterol hydrochloride tablets.
  Spangler, D. L., Lutz, C. N., Tinkelman, D.> ;Ann Allergy. 1987 Jan
• Terbutaline in the treatment of chronic urticaria.
  Spangler, D. L., Vanderpool, G. E., Carroll, M. S., Tinkelman, D. G.> ;Ann Allergy. 1980 Oct
• Flunisolide aerosol in the treatment of perennial allergic rhinitis.
  Bloom, F. L., Cohan, R. H., Leifer, K. N., Spangler, D. L., Rhoades, R. B., Wittig, H. J.> ;Ann Allergy. 1977 Jun
• Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
  Tinkelman, D. G., DeJong, R., Lutz, C., Spangler, D. L.> ;J Allergy Clin Immunol. 1990 Apr
• Join now to see all